• Related News:
  • Tolterodine May Be Safer Than Oxybutynin in Frail Elderly
  • Combined Effects of HBV, HCV on Hepatoma Vary by Age, Gender
  • Simvastatin Beats Metformin in PCOS Therapy
  • Childhood Vaccine Funds Agreed for More Poor Nations
  • Childhood Vaccine Funds Agreed for More Poor Nations
 
  • Affiliates:
  • Phentramin-D Reviews - Phentramin-d reviewed at phentramin-d.us. Learn why Phentramin-d is the best non-prescription diet pill that you can buy online.
  • Adipex Diet Pills - Find the best diet pills that work fast at DietPill.us - buy Phentramin-D, the best non-prescription diet pill.
  • Phentermine - Buy the best diet pills online like Phentermine 37.5, Adipex and Phentramin-d - Order Phentermine & Adipex alternatives today from PhentermineAdipex.org
  • herbalife - Independent Herbalife Distributor in India
  • online prescription -saves you from this problem of waiting for your turn and gives you the ease of getting your medicines prescribed in an easy manner.
  • nasal rinse -If you've heard of the neti pot, you'll love the Water Pik neti bottle featuring the gentlest sinus rinse on the market. The neti bottle reduces your risk of cold and allergy symptoms while providing immediate sinus relief.

Latest Technologies in the Medical World

Dutch Engineers Make Robot Legs for Stroke Patients

robot legs for stroke patientsA group of scientists in the Netherlands created robotic legs to try improving the movements of stroke patients.

The Lower-extremity Powered Exoskeleton or LOPES works by training the body and mind to recover a more natural step and it is hoped to have a commercial version made available to rehabilitation centers around the world.

Experts believe the possibilities are diverse and it hopes therapeutic advances to aid human performance of stroke victims.

UK Doctors Lead Europe’s Primary Embryonic Stem Cell Testing

primary embryonic stem cell testingThe first clinical trial using human embryonic stem cells have been given consent to carry out have been initialized at Moorfields Eye Hospital.

They will introduce retinal cells into the eyes of twelve patients with an untreatable disease, Stargardt’s macular dystrophy, which causes progressive vision loss that affects one in 10,000 people around the world.

The trial test will test the safety of using substitute retinal cells identified as retinal pigment epithelial cells which are obtained from human embryo embryonic stem cells.